Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis

18 September 2019 - In this study, the investigators examined the characteristics of randomised controlled trials that supported approval of cancer ...

Read more →

5 people setting EU drug prices

19 September 2019 - Politic’s guide to the policy makers debating how to calculate the cost of cures. ...

Read more →

FDA continues to take steps to fulfil its commitment to strengthen and modernise the 510(k) medical device program

19 September 2019 - The U.S. FDA today announced that, as a first step toward implementation of the recently established Safety ...

Read more →

McConnell warns Pelosi's drug pricing plan is DOA

19 September 2019 - Senate Republicans are warning Speaker Nancy Pelosi that her much-anticipated drug pricing plan is dead and ...

Read more →

Novartis has submitted application to EMA for approval of Cosentyx in nr-axSpA, which would be the fourth indication

17 September 2019 - 52-week data from the PREVENT study, to support FDA submission, are expected later in the year. ...

Read more →

Pelosi’s drug plan would let U.S. negotiate prices of 250 medications

19 September 2019 - Speaker Nancy Pelosi on Thursday released her long-awaited plan to curb soaring prices of prescription drugs, ...

Read more →

Flawed evidence underpins approval of new cancer drugs

18 September 2019 - We must raise the bar to ensure real benefits for patients ...

Read more →

Why prescription drugs cost so much more in America

19 September 2019 - The US spends more per capita on medication than anywhere else in the world. It’s a key ...

Read more →

Electronic prescribing

19 September 2019 - Electronic Prescribing will provide an option for prescribers (including doctors, dentists, optometrists, midwives and nurse practitioners), and ...

Read more →

FDA grants fast track designation for SPI-1005 in the treatment of Meniere's disease

18 September 2019 - Sound Pharmaceuticals is pleased to announce that the FDA's Division of Neurology Products has granted its request ...

Read more →

Xanax still being overprescribed despite policy changes

19 September 2019 - Patients are still being prescribed hundreds of Xanax tablets a year despite a cut in government ...

Read more →

Medicare Part D rebates ‘substantially’ reduced drug spending, but not enough to offset price hikes

18 September 2019 - As controversy continues over prescription drug pricing, a new study finds that Medicare Part D spent ...

Read more →

Baby Pia: almost 1 million Belgians pay for life-saving drug

18 September 2019 - More than 950,000 Belgians have responded to a couple seeking €1.9m ($2m; £1.7m) to cover the ...

Read more →

Health technology agency insights: informing modification of a qualitative benefit risk framework for health technology reassessment of prescription medications

16 September 2019 - This study's intent was to determine if a qualitative benefit risk framework could be used or modified ...

Read more →

Health insurance that doesn’t cover the bills has flooded the market under Trump

18 September 2019 - The administration’s moves to weaken the Affordable Care Act have taken hold, and companies are cashing in. ...

Read more →